Mandate

Vinge has advised Procuritas in connection with the sale of Ouriginal Group

Vinge has advised Procuritas, the private equity investor focused on investing in and growing Nordic mid-market companies, in connection with the sale of Ouriginal Group to Turnitin LLC, a global leader in academic integrity and education software.

Ouriginal, a company formed from the union of Urkund and PlagScan, has over three decades of experience in combining text-matching with writing-style analysis to promote academic integrity and prevent plagiarism in schools and universities.

Vinge’s team consisted of Jonas Johansson, Karl Klackenberg and Ellinor Wargenbrant (M&A), Mathilda Persson (IT), Tobias Kempas (IP), Sebastian Örndahl and Victoria Fredén (Competition) and Viktoria Owetz Leyva (VDR).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024